资讯
1 天
MedPage Today on MSNNovel Eye Drops for Age-Related Blurry Vision Win FDA ApprovalThe FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, ...
By Foo Yun Chee BRUSSELS (Reuters) -Dutch technology investor Prosus is set to win EU antitrust approval for its 4.1 billion ...
Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss ...
6 天
YourTango on MSN11 Signs Of A Woman Who’s Done Chasing Approval For GoodWomen are conditioned to seek approval from birth, but once we learn the most important approval comes from within, we do ...
The Senate on Friday passed its first tranche of government funding bills for fiscal year 2026 ahead of its upcoming August ...
Union Pacific is seeking to buy Norfolk Southern in a $85 billion deal that would create the first transcontinental railroad ...
6 天
ABP News on MSNIndia-UK FTA A Historic 'Win-Win Deal', Secures 99 Per Cent Duty Free Access, Says Piyush GoyalSpeaking in New Delhi, Goyal stressed that the deal would unlock “immense opportunities” for India’s farmers, fishermen, ...
In the latest round of funding awards from the North Dakota Industrial Commission, $700,000 in Renewable Energy Program ...
3 天
GlobalData on MSNAlfasigma sets stage for Jyseleca in axSpA after Phase III winAlfasigma is in discussions with the EMA and MHRA about Jyseleca for axSpA but has yet to reveal any plans for US submission.
Democratic Party favorability has plunged to 33% in a Wall Street Journal poll, marking a 35-year low as the party struggles ...
Patrick Kiprop, Kenya: Kiprop, 25, has already had success on American roads this year, winning the Peachtree 10K (27:35) in ...
The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果